Does Rallies show 13F holders for HSTM?

Yes. Rallies tracks hedge fund and 13F ownership data for HSTM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is HSTM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HSTM. It does not provide personalized investment advice.

HSTM (HealthStream Inc) Stock Analysis - Hedge Fund Holdings

HealthStream Inc (HSTM) is a publicly traded Healthcare sector company. As of May 21, 2026, HSTM trades at $23.88 with a market cap of $694.15M and a P/E ratio of 36.26. HSTM moved -2.03% today. Year to date, HSTM is +3.86%; over the trailing twelve months it is -16.51%. Its 52-week range spans $19.50 to $34.24. Analyst consensus is buy with an average price target of $32.00. Rallies surfaces HSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns HSTM stock?

Hedge funds tracked by Rallies that own HSTM include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HealthStream Inc.

HSTM Key Metrics

Key financial metrics for HSTM
Metric	Value
Price	$23.88
Market Cap	$694.15M
P/E Ratio	36.26
EPS	$0.67
Dividend Yield	0.04%
52-Week High	$34.24
52-Week Low	$19.50
Volume	16
Avg Volume	0
Revenue (TTM)	$311.78M
Net Income	$19.92M
Gross Margin	0.00%

Top Hedge Funds Holding HSTM

Panagora Asset holds 215.23K shares of HSTM, changed +0.69% as of Mar 31, 2026.
Mangrove Partners holds 8.69K shares of HSTM, changed +0.00% as of Dec 31, 2025.

Latest HSTM News

HealthStream Reports 7.4% Q4 Revenue Growth, Canaccord Cuts Target to $21 — Mar 2, 2026
HealthStream Reports Year‐Over‐Year Q4 2025 Revenue Growth, Margin Gains — Feb 26, 2026
HealthStream Q4 EPS Beats by 12.5% as Revenue Rises to $79.7 Million — Feb 24, 2026
HealthStream Q4 Revenues Rise 7.4% to $79.7M, EBITDA Up 16.4%, Dividend Hiked — Feb 23, 2026

Recent HSTM Insider Trades

O'Hara Kevin P sold 3.00K (~$72.23K) on May 20, 2026.
Cunningham Jeff sold 2.10K (~$50.59K) on Dec 10, 2025.
O'Hara Kevin P sold 2.00K (~$48.52K) on Dec 8, 2025.

HSTM Analyst Consensus

4 analysts cover HSTM: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $32.00.

Common questions about HSTM

Who owns HSTM stock?: Hedge funds tracked by Rallies that own HSTM include Panagora Asset and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for HealthStream Inc.
Does Rallies show 13F holders for HSTM?: Yes. Rallies tracks hedge fund and 13F ownership data for HSTM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is HSTM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HSTM. It does not provide personalized investment advice.